SEC Form 4 · accession 0001209191-15-082280
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas F Kearns Jr.
Director
Period of report
Nov 23, 2015
Accepted (ET)
Nov 25, 2015 · 5:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 23, 2015 | S | 3,900 | $28.02 | D | 173,836 | D | |
| Common StockF1,F3 | Nov 24, 2015 | S | 1,000 | $28.46 | D | 172,836 | D | |
| Common StockF1,F4 | Nov 24, 2015 | S | 2,900 | $29.19 | D | 169,936 | D | |
| Common Stock | holding | — | — | — | 110,000 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 plan.
- F2The shares were sold at prices ranging from $27.49 to $28.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The shares were sold at prices ranging from $28.07 to $28.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The shares were sold at prices ranging from $29.00 to $29.62. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.